AstraZeneca has announced the launch of a robust initiative to promote lung health that includes an informative campaign titled 'Think Simply' and the signing of three memoranda of cooperation with prominent Greek medical organizations. This collaboration focuses on the critical relationship between Chronic Obstructive Pulmonary Disease (COPD) and lung cancer, a connection that is often overlooked but significantly impacts patient diagnosis and overall care.

The initiative seeks to raise public awareness regarding the early diagnosis of these coexisting conditions, which is vital for improved patient outcomes. According to Petros Galanakis, the Medical Director of AstraZeneca Greece, the company's efforts aim to enhance education on the timely detection of both diseases. The collaboration with leading scientific societies in Greece is designed to ensure that their actions will have a meaningful and immediate effect on public health.

Moreover, the campaign will highlight the need for increased recognition of COPD as a significant risk factor for lung cancer. By integrating awareness and collaboration, AstraZeneca strives to not only inform but also to invoke proactive support for lung health, thereby aiming to create a more informed public and ultimately better patient care.